Skip to main content
OK BIOTECH logo

OK BIOTECH — Investor Relations & Filings

Ticker · 4155 ISIN · TW0004155007 TW Manufacturing
Filings indexed 1,730 across all filing types
Latest filing 2025-02-10 Regulatory Filings
Country TW Taiwan
Listing TW 4155

About OK BIOTECH

http://www.okbiotech.com

OK Biotech Co., Ltd. is a medical device company specializing in the research, development, manufacturing, and global distribution of diagnostic and home healthcare solutions. Established in 2004, the company focuses on blood glucose monitoring systems, including high-precision meters and test strips, alongside over-the-counter (OTC) hearing aids and multiple frequency therapy devices. OK Biotech provides comprehensive services ranging from product design to complete factory setup solutions, supporting partners from initial planning through to mass production. By leveraging advanced R&D and production technologies, the company delivers reliable OEM and ODM solutions designed for both personal wellness and professional clinical applications. Its commitment to technical innovation ensures the delivery of high-quality medical instruments and tailored healthcare support to a global market.

Recent filings

Filing Released Lang Actions
114年1月營業收入
Regulatory Filings Classification · 95% confidence The document is a revenue summary report for a specific month (January of year 114 in the Taiwanese calendar, corresponding to 2025) showing net operating revenue figures and percentage changes compared to the previous year. It includes explanatory notes about accounting standards (IFRS) and reporting requirements for listed companies. The document is very short (796 characters) and primarily provides a brief financial summary without detailed financial statements or comprehensive analysis. It does not contain full financial results or management discussion, nor is it an announcement of a meeting or voting results. Given the short length and nature of the content, it is best classified as a Regulatory Filing (RNS), which serves as a general regulatory announcement or compliance document that does not fit other specific categories.
2025-02-10 Chinese
114年01月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, chairman, general manager, and other executives. It shows their share types, holdings at appointment, changes in holdings during the month, and current holdings. The content is focused on insider share transactions and holdings disclosures. There is no indication of financial statements, earnings data, management discussion, or meeting materials. The document is not a report or announcement of a report but a detailed insider shareholding disclosure. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is sufficient and the content is consistent with insider shareholding disclosures rather than other categories like Annual Report, Earnings Release, or Regulatory Filings.
2025-02-10 Chinese
114年01月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledged shares of company insiders, including directors, supervisors, and senior management. It provides specific data on share counts, pledged shares, and related parties' holdings. The content is focused on insider shareholdings and pledging status rather than financial results, management changes, or meeting materials. There is no indication of a report publication, voting results, or legal proceedings. This type of document aligns with a Director's Dealing report, which discloses personal share transactions or holdings by company directors and executives. The document length is about 3,000 characters, which is consistent with a detailed insider shareholding disclosure rather than a full financial report or announcement. Therefore, the most appropriate classification is Director's Dealing (DIRS).
2025-02-10 Chinese
代重要子公司PRODIGY DIABETES CARE, LLC. 公告現金股利配發基準日
Notice of Dividend Amount Classification · 100% confidence The document is a short announcement from a company (4155 訊映) regarding the declaration of a cash dividend by its important subsidiary PRODIGY DIABETES CARE, LLC. It specifies the dividend amount, the record date, and related dates. The content is focused on dividend distribution details rather than a full financial report or other types of filings. The document length is only 642 characters, indicating it is a brief announcement rather than a detailed report. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2025-02-07 Chinese
代重要子公司PRODIGY DIABETES CARE, LLC. 公告董事會決議發放現金股利
Notice of Dividend Amount Classification · 95% confidence The document is a short announcement from a company about a board resolution to distribute cash dividends, specifying the dividend amount and date. It does not contain detailed financial statements or comprehensive report content. The document length is only 511 characters, indicating it is a brief announcement rather than a full report. The key phrase '董事會決議發放現金股利' (board resolution to distribute cash dividends) and the mention of dividend amount align with a Notice of Dividend Amount filing. Therefore, the appropriate classification is Notice of Dividend Amount (DIV).
2025-02-07 Chinese
代重要子公司PRODIGY DIABETES CARE, LLC. 公告現金股利配發基準日
Notice of Dividend Amount Classification · 100% confidence The document is a short announcement from a company regarding the declaration of a cash dividend distribution date and related details such as the dividend amount and the ex-dividend date. It does not contain financial statements or detailed financial analysis. The document length is only 642 characters, indicating it is a brief notice rather than a full report. The content matches the definition of a Notice of Dividend Amount (DIV), which includes announcements of dividend amounts, payment dates, and details for shareholders.
2025-01-17 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.